Anthony Cerami
Anthony Cerami
Rockefeller Univ, Picower Institute, Warren Institute, Araim Pharmaceuticals
Verified email at
Cited by
Cited by
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
M Brownlee, A Cerami, H Vlassara
New England Journal of Medicine 318 (20), 1315-1321, 1988
Shock and tissue injury induced by recombinant human cachectin
KJ Tracey, B Beutler, SF Lowry, J Merryweather, S Wolpe, IW Milsark, ...
Science 234 (4775), 470-474, 1986
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
KJ Tracey, Y Fong, DG Hesse, KR Manogue, AT Lee, GC Kuo, SF Lowry, ...
Nature 330 (6149), 662-664, 1987
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
B Beutler, IW Milsark, AC Cerami
Science 229 (4716), 869-871, 1985
The biology of cachectin/TNF--a primary mediator of the host response
B Beutler, A Cerami
Annual review of immunology 7 (1), 625-655, 1989
Detection of circulating tumor necrosis factor after endotoxin administration
HR Michie, KR Manogue, DR Spriggs, A Revhaug, S O'Dwyer, ...
New England Journal of Medicine 318 (23), 1481-1486, 1988
Cachectin and tumour necrosis factor as two sides of the same biological coin
B Beutler, A Cerami
Nature 320 (6063), 584-588, 1986
Cachectin: more than a tumor necrosis factor
B Beutler, A Cerami
New England Journal of Medicine 316 (7), 379-385, 1987
Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators
D Caput, B Beutler, K Hartog, R Thayer, S Brown-Shimer, A Cerami
Proceedings of the National Academy of Sciences 83 (6), 1670-1674, 1986
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
CA Dinarello, JG Cannon, SM Wolff, HA Bernheim, B Beutler, A Cerami, ...
The Journal of experimental medicine 163 (6), 1433-1450, 1986
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
ML Brines, P Ghezzi, S Keenan, D Agnello, NC De Lanerolle, C Cerami, ...
Proceedings of the National Academy of Sciences 97 (19), 10526-10531, 2000
Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance
B Beutler, N Krochin, IW Milsark, C Luedke, A Cerami
Science 232 (4753), 977-980, 1986
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
B Beutler, D Greenwald, JD Hulmes, M Chang, YCE Pan, J Mathison, ...
Nature 316 (6028), 552-554, 1985
Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus
RJ Koenig, CM Peterson, RL Jones, C Saudek, M Lehrman, A Cerami
New England Journal of Medicine 295 (8), 417-420, 1976
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
JM Dayer, B Beutler, AC Cerami
The Journal of experimental medicine 162 (6), 2163-2168, 1985
Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
M Brownlee, H Vlassara, A Kooney, P Ulrich, A Cerami
Science 232 (4758), 1629-1632, 1986
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.
R Bucala, KJ Tracey, A Cerami
The Journal of clinical investigation 87 (2), 432-438, 1991
Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair
R Bucala, LA Spiegel, J Chesney, M Hogan, A Cerami
Molecular medicine 1 (1), 71-81, 1994
MIF as a glucocorticoid-induced modulator of cytokine production
T Calandra, J Bernhagen, CN Metz, LA Spiegel, M Bacher, T Donnelly, ...
Nature 377 (6544), 68-71, 1995
Nonenzymatic glycosylation and the pathogenesis of diabetic complications
M Brownlee, H VLASSARA, A Cerami
Annals of internal medicine 101 (4), 527-537, 1984
The system can't perform the operation now. Try again later.
Articles 1–20